Tandem Diabetes Care Aktie [WKN DE: A1W8XG / ISIN: US8753721047]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Tandem Diabetes Care Inc

21.11.24		Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
06.11.24		Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance (Businesswire)
30.10.24		Tandem Diabetes Care Announces Upcoming Conference Participation (Businesswire)
02.10.24		Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024 (Businesswire)
19.09.24		Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union (Businesswire)
26.08.24		Tandem Diabetes Care Announces Upcoming Conference Participation (Businesswire)
20.08.24		Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall (Businesswire)
12.08.24		Tandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS Devices (Businesswire)
01.08.24		Tandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance (Businesswire)
30.07.24		Tandem Diabetes Care Announces Upcoming Conference Presentation (Businesswire)
29.07.24		Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada (Businesswire)
11.07.24		Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024 (Businesswire)
22.06.24		Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions (Businesswire)
20.06.24		Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer (Businesswire)
18.06.24		Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions (Businesswire)
29.05.24		Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM (Businesswire)
23.05.24		Tandem Diabetes Care Announces Upcoming Conference Presentation (Businesswire)
02.05.24		Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance (Businesswire)
29.04.24		Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
09.04.24		Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024 (Businesswire)
06.03.24		Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029 (Businesswire)
04.03.24		Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes (Businesswire)
13.02.24		Tandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery System (Businesswire)
08.02.24		Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
22.01.24		Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 (Businesswire)
08.01.24		Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor (Businesswire)
12.12.23		Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers (Businesswire)
06.12.23		Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S. (Businesswire)
06.11.23		Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
01.11.23		Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer (Businesswire)
24.08.23		Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
03.08.23		Tandem Diabetes Care Announces Technology Access Program to Provide Customers with Purchase Pathway to the Tandem Mobi System (Businesswire)
01.08.23		Tandem Diabetes Care to Present at the UBS MedTech, Tools and Genomics Summit 2023 (Businesswire)
11.07.23		Tandem Mobi, World’s Smallest Durable Insulin Delivery System, Receives FDA Clearance (Businesswire)
10.07.23		Tandem Diabetes Care to Announce Second Quarter 2023 Financial Results on August 3, 2023 (Businesswire)
24.05.23		Tandem Diabetes Care to Present at the Jefferies Healthcare Conference (Businesswire)
03.05.23		Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance (Businesswire)
20.04.23		Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference (Businesswire)
17.04.23		Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes (Businesswire)
11.04.23		Tandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023 (Businesswire)
15.03.23		Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ Technology (Businesswire)
22.02.23		Tandem Diabetes Care Appoints New Chair of Board of Directors (Businesswire)
15.02.23		Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
23.01.23		Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical (Businesswire)
19.01.23		Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023 (Businesswire)
10.01.23		Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 Outlook (Businesswire)
03.01.23		Tandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare Conference (Businesswire)
13.12.22		Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical (Businesswire)
16.11.22		Tandem Diabetes Care Earns Great Place to Work Certification™ (Businesswire)
10.11.22		Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ Technology (Businesswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

Pierer Mobility-Aktie unter Druck: KTM-Pleite - Schockstarre in der Region und bei den Zulieferern - Land OÖ signalisiert Bereitschaft Beschäftigten zu helfen

voestalpine-Aktie zieht an: Erste Group stuft Aktie von "Accumulate" auf "Buy" hoch

Solana Kurs Prognose: 300 US-Dollar noch in diesem Jahr?

Rosenbauer erwartet kein Problem bei Kapitalerhöhung wegen KTM-Pleite - Rosenbauer-Aktie fester

Pierer Mobility-Aktie bricht ein: KTM steht vor Insolvenz

Pierer Mobility-Aktie zieht zweistellig an: Pierer Industrie AG hat Restrukturierungsverfahren eingeleitet

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	30.11.2024 05:20
Kaufwert:	EUR
	Hinzufügen Speichern